natgillin/translations-raw huggingface dataset:
The Agreement between the European Union and the Republic of Mauritius amending the Agreement between the European Community and the Republic of Mauritius on the short-stay visa waiver is hereby approved on behalf of the Union.
Sporazum med Evropsko unijo in Republiko Mauritius o spremembi Sporazuma med Evropsko skupnostjo in Republiko Mauritius o odpravi vizumov za kratkoročno bivanje se odobri v imenu Unije.
Council Decision 2009/899/EC of 30 November 2009 on the conclusion of the Agreement between the European Community and the Republic of Mauritius on the short-stay visa waiver (OJ L 321, 8.12.2009, p. 41).
Sklep Sveta 2009/899/ES z dne 30. novembra 2009 o sklenitvi Sporazuma med Evropsko skupnostjo in Republiko Mauritius o odpravi vizumov za kratkoročno bivanje (UL L 321, 8.12.2009, str. 41).
Council Decision (EU) 2017/2087 of 6 November 2017 on the signing, on behalf of the Union, of the Agreement between the European Union and the Republic of Mauritius amending the Agreement between the European Community and the Republic of Mauritius on the short-stay visa waiver (OJ L 297, 15.11.2017, p. 9).
Sklep Sveta (EU) 2017/2087 z dne 6. novembra 2017 o sklenitvi, v imenu Unije, Sporazuma med Evropsko unijo in Republiko Mauritius o spremembi Sporazuma med Evropsko skupnostjo in Republiko Mauritius o odpravi vizumov za kratkoročno bivanje (UL L 297, 15.11.2017, str. 9).
Council Decision (EU) 2019/79
Sklep Sveta (EU) 2019/79
on the conclusion, on behalf of the Union, of the Agreement between the European Union and the Republic of Seychelles amending the Agreement between the European Community and the Republic of Seychelles on the short-stay visa waiver
o sklenitvi, v imenu Unije, Sporazuma med Evropsko unijo in Republiko Sejšeli o spremembi Sporazuma med Evropsko skupnostjo in Republiko Sejšeli o odpravi vizumov za kratkoročno bivanje
By its Decision 2009/900/EC, the Council concluded the Agreement between the European Community and the Republic of Seychelles on the short-stay visa waiver (the ‘Agreement’).
Svet je s Sklepom 2009/900/ES sklenil Sporazum med Evropsko skupnostjo in Republiko Sejšeli o odpravi vizumov za kratkoročno bivanje (v nadaljnjem besedilu: Sporazum).
The Agreement provides for visa-free travel for the citizens of the Union and for the citizens of the Republic of Seychelles when travelling to the territory of the other Contracting Party for a maximum period of three months during a six months period.
Sporazum državljanom Unije ter državljanom Sejšelov omogoča potovanje brez vizumov na ozemlje druge pogodbenice za največ tri mesece v obdobju šestih mesecev.
The Commission has negotiated, on behalf of the Union, an agreement with the Republic of Seychelles which amends the Agreement between the European Community and the Republic of Seychelles on the short-stay visa waiver (the amending ‘Agreement’).
Komisija je v imenu Unije s pogajanji dosegla sporazum z Republiko Sejšeli o spremembi Sporazuma med Evropsko skupnostjo in Republiko Sejšeli o odpravi vizumov za kratkoročno bivanje (v nadaljnjem besedilu: Sporazum o spremembi).
In accordance with Council Decision (EU) 2017/2088, the amending Agreement has been signed.
V skladu s Sklepom Sveta (EU) 2017/2088 je bil Sporazum o spremembi podpisan.
The amending Agreement should be approved,
Sporazum bi bilo treba odobriti –
The Agreement between the European Union and the Republic of Seychelles amending the Agreement between the European Community and the Republic of Seychelles on the short-stay visa waiver is hereby approved on behalf of the Union.
Sporazum med Evropsko unijo in Republiko Sejšeli o spremembi Sporazuma med Evropsko skupnostjo in Republiko Sejšeli o odpravi vizumov za kratkoročno bivanje se odobri v imenu Unije.
Council Decision 2009/900/EC of 30 November 2009 on the conclusion of the Agreement between the European Community and the Republic of Seychelles on the short-stay visa waiver (OJ L 321, 8.12.2009, p. 42).
Sklep Sveta 2009/900/ES z dne 30. novembra 2009 o sklenitvi Sporazuma med Evropsko skupnostjo in Republiko Sejšeli o odpravi vizumov za kratkoročno bivanje (UL L 321, 8.12.2009, str. 42).
Council Decision (EU) 2017/2088 of 6 November 2017 on the signing, on behalf of the Union, of the Agreement between the European Union and the Republic of Seychelles amending the Agreement between the European Community and the Republic of Seychelles on the short-stay visa waiver (OJ L 297, 15.11.2017, p. 11).
Sklep Sveta (EU) 2017/2088 z dne 6. novembra 2017 o sklenitvi, v imenu Unije, Sporazuma med Evropsko unijo in Republiko Sejšeli o spremembi Sporazuma med Evropsko skupnostjo in Republiko Sejšeli o odpravi vizumov za kratkoročno bivanje (UL L 297, 15.11.2017, str. 11).
Council Decision (EU) 2019/80
Sklep Sveta (EU) 2019/80
on the conclusion, on behalf of the Union, of the Agreement between the European Union and the Federation of St Kitts and Nevis amending the Agreement between the European Community and the Federation of Saint Kitts and Nevis on the short-stay visa waiver
o sklenitvi, v imenu Unije, Sporazuma med Evropsko unijo ter Federacijo Saint Kitts in Nevis o spremembi Sporazuma med Evropsko skupnostjo ter Federacijo Saint Kitts in Nevis o odpravi vizumov za kratkoročno bivanje
Having regard to the Treaty on the Functioning of the European Union, and in particular point (a) of Article 77(2), in conjunction with point (a)(v) of the second subparagraph of Article 218(6) thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti točke (a) člena 77(2) v povezavi s točko (a)(v) drugega pododstavka člena 218(6) Pogodbe,
By its Decision 2009/901/EC, the Council concluded the Agreement between the European Community and the Federation of Saint Kitts and Nevis on the short-stay visa waiver (the ‘Agreement’).
Svet je s sklepom2009/901/ES sklenil Sporazum med Evropsko skupnostjo ter Federacijo Saint Kitts in Nevis o odpravi vizumov za kratkoročno bivanje (v nadaljnjem besedilu: Sporazum).
The Agreement provides for visa-free travel for the citizens of the Union and for the citizens of the Federation of Saint Kitts and Nevis when travelling to the territory of the other Contracting Party for a maximum period of three months during a six months period.
Sporazum državljanom Unije ter državljanom Federacije Saint Kitts in Nevis omogoča potovanje brez vizumov na ozemlje druge pogodbenice za največ tri mesece v obdobju šestih mesecev.
Regulation (EU) No 610/2013 of the European Parliament and of the Council introduced horizontal changes in the Union's visa and border acquis and defined a short stay as a maximum of 90 days in any 180-day period.
Uredba (EU) št. 610/2013 Evropskega parlamenta in Sveta je uvedla horizontalne spremembe v pravnem redu Unije na področju vizumov in mej ter opredelila kratkoročno bivanje kot največ 90 dni v katerem koli 180-dnevnem obdobju.
The Commission has negotiated, on behalf of the Union, an agreement with the Federation of Saint Kitts and Nevis which amends the Agreement between the European Community and the Federation of Saint Kitts and Nevis on the short-stay visa waiver (the ‘amending Agreement’).
Komisija je v imenu Unije s pogajanji dosegla sporazum s Federacijo Saint Kitts in Nevis o spremembi Sporazuma med Evropsko skupnostjo ter Federacijo Saint Kitts in Nevis o odpravi vizumov za kratkoročno bivanje (v nadaljnjem besedilu: Sporazum o spremembi).
In accordance with Council Decision (EU) 2017/2086, the amending Agreement has been signed.
V skladu s Sklepom Sveta (EU) 2017/2086 je bil Sporazum o spremembi podpisan.
This Decision constitutes a development of the provisions of the Schengen acquis in which Ireland does not take part, in accordance with Council Decision 2002/192/EC; Ireland is therefore not taking part in the adoption of this Decision and is not bound by it or subject to its application.
Ta sklep predstavlja razvoj določb schengenskega pravnega reda, pri katerih Irska v skladu s Sklepom Sveta 2002/192/ES ne sodeluje; Irska torej ne sodeluje pri sprejetju tega sklepa, ki zato zanjo ni zavezujoč in se v njej ne uporablja –
The amending Agreement should be approved,
Sporazum o spremembi bi bilo treba odobriti –
The Agreement between the European Union and the Federation of Saint Kitts and Nevis amending the Agreement between the European Community and the Federation of Saint Kitts and Nevis the short-stay visa waiver is hereby approved on behalf of the Union.
Sporazum med Evropsko unijo ter Federacijo Saint Kitts in Nevis o spremembi Sporazuma med Evropsko skupnostjo ter Federacijo Saint Kitts in Nevis o odpravi vizumov za kratkoročno bivanje se odobri v imenu Unije.
The President of the Council shall, on behalf of the Union, give the notification provided for in Article 2 of the amending Agreement.
Predsednik Sveta v imenu Unije pošlje uradno obvestilo iz člena 2 Sporazuma o spremembi.
Council Decision 2009/901/EC of 30 November 2009 on the conclusion of the Agreement between the European Community and the Federation of Saint Kitts and Nevis on the short-stay visa waiver (OJ L 321, 8.12.2009, p. 43).
Sklep Sveta 2009/901/ES z dne 30. novembra 2009 o sklenitvi Sporazuma med Evropsko skupnostjo ter Federacijo Saint Kitts in Nevis o odpravi vizumov za kratkoročno bivanje (UL L 321, 8.12.2009, str. 43).
Council Decision (EU) 2017/2086 of 6 November 2017 on the signing, on behalf of the Union, of the Agreement between the European Union and the Federation of Saint Kitts and Nevis amending the Agreement between the European Community and the Federation of Saint Kitts and Nevis on the short-stay visa waiver (OJ L 297, 15.11.2017, p. 7).
Sklep Sveta (EU) 2017/2086 z dne 6. novembra 2017 o podpisu, v imenu Unije, Sporazuma med Evropsko unijo in Federacijo Saint Kitts in Nevis o spremembi Sporazuma med Evropsko skupnostjo in Federacijo Saint Kitts in Nevis o odpravi vizumov za kratkoročno bivanje (UL L 297, 15.11.2017, str. 7).
The maximum period of 90 days in any 180-day period will be calculated taking into account the period of stay in all the Member States operating the Entry/Exit System at the external borders.
Obdobje največ 90 dni v katerem koli obdobju 180 dni se bo izračunalo ob upoštevanju trajanja bivanja v vseh državah članicah, ki uporabljajo sistem vstopa/izstopa na zunanjih mejah.
The date of application will be decided by the Commission in accordance with Article 73 of Regulation (EU) 2017/2226.
Datum začetka uporabe bo v skladu s členom 73 Uredbe (EU) 2017/2226 določila Komisija.
Commission Implementing Decision (EU) 2019/81
Izvedbeni sklep Komisije (EU) 2019/81
of 17 January 2019
z dne 17. januarja 2019
amending Annex I to Implementing Decision (EU) 2016/2008 concerning animal health control measures relating to lumpy skin disease in certain Member States
o spremembi Priloge I k Izvedbenemu sklepu (EU) 2016/2008 o nadzornih ukrepih za zdravje živali v zvezi z vozličastim dermatitisom v nekaterih državah članicah
(notified under document C(2019) 102)
(notificirano pod dokumentarno številko C(2019) 102)
Having regard to Council Directive 92/119/EEC of 17 December 1992 introducing general Community measures for the control of certain animal diseases and specific measures relating to swine vesicular disease, and in particular Article 14(2), Article 19(1)(a) and(3)(a) and Article 19(4) and (6) thereof,
ob upoštevanju Direktive Sveta 92/119/EGS z dne 17. decembra 1992 o splošnih ukrepih Skupnosti za nadzor nad določenimi živalskimi boleznimi in o posebnih ukrepih v primeru vezikularne bolezni prašičev ter zlasti člena 14(2), člena 19(1)(a) in (3)(a) ter člena 19(4) in (6) Direktive,
These control measures include the establishment of protection and surveillance zones around the infected holding, and they also provide for emergency vaccination in the case of an outbreak of LSD in addition to other control measures.
Ti nadzorni ukrepi vključujejo vzpostavitev okuženih in ogroženih območij okoli okuženega gospodarstva ter določajo tudi cepljenje v izrednih razmerah v primeru izbruha vozličastega dermatitisa kot dopolnilo k drugim nadzornim ukrepom.
Commission Implementing Decision (EU) 2016/2008 lays down animal health control measures to be taken in relation to outbreaks of LSD in the Member States or parts thereof as listed in Annex I thereto, including the minimum requirements for vaccination programmes against LSD submitted by the Member States to the Commission for approval.
Izvedbeni sklep Komisije (EU) 2016/2008 določa nadzorne ukrepe za zdravje živali, ki jih je treba sprejeti v zvezi z izbruhi vozličastega dermatitisa v državah članicah ali njihovih delih, navedenih v Prilogi I k navedenemu izvedbenemu sklepu, vključno z minimalnimi zahtevami za programe cepljenja proti vozličastemu dermatitisu, predložene s strani držav članic Komisiji v odobritev.
Implementing Decision (EU) 2016/2008 defines ‘infected zones’ as the part of the territory of a Member State listed in Part II of Annex I thereto, which includes the area where LSD was confirmed and any protection and surveillance zones established in accordance with Directive 92/119/EEC, and where vaccination against LSD may be implemented following the approval of vaccination programmes.
V Izvedbenem sklepu (EU) 2016/2008 je „okuženo območje“ opredeljeno kot del ozemlja države članice iz dela II Priloge I k navedenemu izvedbenemu sklepu, ki vključuje območje, na katerem je bil potrjen vozličasti dermatitis, ter vsa okužena in ogrožena območja, vzpostavljena v skladu z Direktivo 92/119/EGS, in na katerih se cepljenje proti vozličastemu dermatitisu lahko izvaja po odobritvi programov cepljenja.
It also defines ‘free zones with vaccination’ as the part of the territory of a Member State listed in Part I of that Annex which includes the areas outside the infected zones, where vaccination against LSD is implemented following the approval of vaccination programmes.
Navedeni izvedbeni sklep opredeljuje tudi „prosto območje s cepljenjem“, in sicer kot del ozemlja države članice iz dela I navedene priloge, ki vključuje območja zunaj „okuženega območja“ in na katerem se cepljenje proti vozličastemu dermatitisu izvaja po odobritvi programov cepljenja.
In August 2015, LSD was confirmed in Greece for the first time.
Vozličasti dermatitis je bil prvič potrjen avgusta 2015 v Grčiji.
In 2016, there were cases of LSD in Bulgaria and additional cases in Greece, as well as in a number of neighbouring third countries.
Leta 2016 so bili v Grčiji odkriti novi primeri vozličastega dermatitisa, bolezen pa se je pojavila tudi v Bolgariji in nekaterih sosednjih tretjih državah.
In 2017, LSD was present to a lesser extent in South-East Europe, with a large scale recurrence of the disease in Albania, and a few additional sporadic outbreaks in Greece and the former Yugoslav Republic of Macedonia.
Leta 2017 je bil vozličasti dermatitis v manjši meri prisoten v jugovzhodni Evropi, in sicer se je bolezen v velikem obsegu ponovno pojavila v Albaniji, poleg tega pa je prišlo do nekaj posamičnih izbruhov v Grčiji in nekdanji jugoslovanski republiki Makedoniji.
In 2018, there has been an improvement of the LSD epidemiological situation and no case of LSD has been reported in any Member State or in any neighbouring third country in South-East Europe, excluding Turkey.
Leta 2018 je prišlo do izboljšanja epidemioloških razmer glede vozličastega dermatitisa in primeri te bolezni niso bili sporočeni v nobeni državi članici ali sosednji tretji državi v jugovzhodni Evropi, razen v Turčiji.
In response to the outbreaks of LSD, the affected Member States, namely Greece and Bulgaria, as well as the affected neighbouring third countries, implemented mass vaccination programmes of their live bovine animals and captive wild ruminants.
V odgovor na izbruhe vozličastega dermatitisa so prizadeti državi članici, tj. Grčija in Bolgarija, in vse prizadete sosednje tretje države uvedle programe masovnega cepljenja živega goveda in divjih prežvekovalcev v ujetništvu.
Croatia, where LSD has not occurred to date, also implemented a mass vaccination programme against LSD, in 2016 and 2017, as a preventive measure in view of the epidemiological situation in neighbouring Member States and third countries.
V letih 2016 in 2017 je program masovnega cepljenja izvajala tudi Hrvaška, v kateri vozličasti dermatitis do takrat še ni bil prisoten, in sicer kot preventivni ukrep zaradi epidemioloških razmer v sosednjih državah članicah in tretjih državah.
The LSD vaccination programmes in Greece, Bulgaria and Croatia were approved by the Commission under Commission Implementing Decision (EU) 2016/2009.
Komisija je programe cepljenja proti vozličastemu dermatitisu v Grčiji, Bolgariji in na Hrvaškem odobrila z Izvedbenim sklepom Komisije (EU) 2016/2009.
Since the first occurrence of LSD in continental Europe, the European Food Safety Authority (EFSA) has produced an ‘Urgent advice on LSD, adopted on 29 July 2016 and three reports, namely ‘Lumpy skin disease: I. Data collection and analysis’ approved on 27 March 2017, ‘Lumpy skin disease II.
Od prvega pojava vozličastega dermatitisa v celinski Evropi je Evropska agencija za varnost hrane (EFSA) pripravila nujno obvestilo o vozličastem dermatitisu, sprejeto 29. julija 2016, ter tri poročila, in sicer „Vozličasti dermatitis I. Zbiranje in analiza podatkov“, odobreno 27. marca 2017, „Vozličasti dermatitis II.
Data collection and analysis’ approved on 29 January 2018 and ‘Lumpy skin disease: scientiﬁc and technical assistance on control and surveillance activities’ approved on 28 September 2018.
Zbiranje in analiza podatkov“, odobreno 29. januarja 2018, ter „Vozličasti dermatitis: znanstvena in tehnična pomoč pri dejavnostih nadzora“, odobreno 28. septembra 2018.
All these scientific assessments suggest that mass vaccination campaigns against LSD, when they are properly implemented, bring the disease under control by preventing the occurrence of new outbreaks.
Vse navedene znanstvene ocene kažejo, da je z akcijami masovnega cepljenja proti vozličastemu dermatitisu, če se ustrezno izvajajo, s preprečevanjem pojava novih izbruhov bolezen mogoče nadzorovati.
Mass vaccination against LSD has continued in 2018 in all the Member States and neighbouring third countries in South-East Europe that have been affected by LSD.
V letu 2018 se je v vseh državah članicah in sosednjih tretjih državah v jugovzhodni Evropi, ki jih je prizadel vozličasti dermatitis, še naprej izvajalo masovno cepljenje proti tej bolezni.
Since the beginning of 2018, Croatia has stopped vaccination against LSD in view of the favourable epidemiological situation in that Member State and in neighbouring third countries.
Hrvaška zaradi ugodnih epidemioloških razmer v tej državi članici in sosednjih tretjih državah od začetka leta 2018 tovrstnega cepljenja ne izvaja več.
Instead, Croatia started implementing a LSD surveillance programme approved by the Commission.
Namesto tega je začela izvajati program nadzora vozličastega dermatitisa, ki ga je odobrila Komisija.
That programme involves clinical, virological and serological surveillance with an emphasis on high risk areas, situated close to Member States and neighbouring third countries where outbreaks of LSD have been reported in recent years.
Navedeni program vključuje klinični, virološki in serološki nadzor s poudarkom na območjih z visokim tveganjem, ki se nahajajo v bližini držav članic in sosednjih tretjih držav, v katerih so bili v zadnjih letih sporočeni izbruhi vozličastega dermatitisa.
In accordance with Article 11.9.4 of the Terrestrial Animal Health Code of the World Health Organisation for Animal Health (OIE), in the case of preventive vaccination, conducted in a country or zone free from LSD, in response to a threat but without the occurrence of a case of LSD, disease-free status may be regained eight months after the last vaccination when clinical, virological and serological surveillance has been conducted in accordance with Article 11.9.15 of that Code.
V skladu s členom 11.9.4 Zoosanitarnega kodeksa za kopenske živali Svetovne organizacije za zdravje živali (v nadaljnjem besedilu: OIE) se lahko v primeru preventivnega cepljenja, ki se izvaja v državi ali na območju brez vozličastega dermatitisa v odgovor na grožnjo, vendar brez pojava primera vozličastega dermatitisa, status brez bolezni ponovno podeli osem mesecev po zadnjem cepljenju, če se je izvedel klinični, virološki in serološki nadzor v skladu s členom 11.9.15 navedenega kodeksa.
According to a report, submitted by Croatia to the Commission on 13 October 2018, the results of clinical, virological and serological surveillance indicate that there is no evidence of the presence of LSD in its territory.
Glede na poročilo, ki ga je Hrvaška predložila Komisiji 13. oktobra 2018, rezultati kliničnega, virološkega in serološkega nadzora kažejo, da ni dokazov o prisotnosti vozličastega dermatitisa na njenem ozemlju.
Hence, Croatia fulfils all OIE requirements for disease-free status for LSD in the absence of the occurrence of LSD cases and since more than eight months have elapsed since the last LSD vaccination.
Hrvaška torej za vozličasti dermatitis izpolnjuje vse zahteve OIE za status brez bolezni, saj ni bil sporočen noben primer navedene bolezni, poleg tega pa je od zadnjega cepljenja proti vozličastemu dermatitisu minilo več kot osem mesecev.
It is therefore appropriate to lift the restrictions in relation to LSD vaccination in that Member State.
Zato je primerno odpraviti omejitve glede cepljenja proti vozličastemu dermatitisu v navedeni državi članici.
As a result, the entry for Croatia should be deleted from the list of Member States with ‘free zones with vaccination’ in Annex I to Implementing Decision (EU) 2016/2008.
Vnos za Hrvaško bi bilo torej treba črtati s seznama držav članic s „prostimi območji s cepljenjem“ v Prilogi I k Izvedbenemu sklepu (EU) 2016/2008.
Annex I to Implementing Decision (EU) 2016/2008 should therefore be amended accordingly.
Prilogo I k Izvedbenemu sklepu (EU) 2016/2008 bi bilo zato treba ustrezno spremeniti.
Annex I to Implementing Decision (EU) 2016/2008 is replaced by the text set out in the Annex to this Decision.
Priloga I k Izvedbenemu sklepu (EU) 2016/2008 se nadomesti z besedilom iz Priloge k temu sklepu.
Done at Brussels, 17 January 2019.
V Bruslju, 17. januarja 2019
OJ L 62, 15.3.1993, p. 69.
UL L 62, 15.3.1993, str. 69.
Commission Implementing Decision (EU) 2016/2009 of 15 November 2016 approving the vaccination programmes against lumpy skin disease submitted by the Member States (OJ L 310, 17.11.2016, p. 66).
Izvedbeni sklep Komisije (EU) 2016/2009 z dne 15. novembra 2016 o odobritvi programov cepljenja proti vozličastemu dermatitisu, ki so jih predložile države članice (UL L 310, 17.11.2016, str. 66).
EFSA Journal 2018;16(2):5176.
PRILOGA I
EFSA Journal 2018;16(10):5452.
DEL I
ANNEX
‚Prosta območja s cepljenjem‘
ANNEX I
Bolgarija
PART I
A. Naslednji okraji v Bolgariji:
“Free zones with vaccination”
okraj Burgas,
Bulgaria
okraj Varna,
A. The following provinces in Bulgaria:
okraj Dobrič,
Province of Burgas
okraj Razgrad,
Province of Varna
okraj Silistra,
Province of Dobrich
okraj Ruse,
Province of Razgrad
okraj Pleven.
Province of Silistra
B. Naslednje občine v Bolgariji:
Province of Ruse
občine Opaka, Popovo in Antonovo v okraju Targovište,
Province of Pleven
občine Šumen, Kaspičan, Novi Pazar, Nikola Kozlevo, Kaolinovo, Venets in Hitrino v okraju Šumen,
B. The following municipalities in Bulgaria:
občine Svištov, Polski Trambeš in Stražica v okraju Veliko Tarnovo.
The municipalities of Opaka, Popovo and Antonovo in the province of Targovishte.
Grčija
The municipalities of Shumen, Kaspichan, Novi Pazar, Nikola Kozlevo, Kaolinovo, Venets and Hitrino in the province of Shumen.
Naslednje regije v Grčiji:
The municipalities of Svishtov, Polski Trambesh and Strazhitsa, in the province of Veliko Tarnovo.
regija Jonski otoki, razen regionalne enote Kerkyra,
Greece
regija Severni Egejski otoki, razen regionalne enote Limnos,
The following regions in Greece:
regija Južni Egejski otoki,
Region of Ionian Islands, excluding the regional unit of Kerkyra
regija Kreta.
Region of North Aegean, excluding the regional unit of Limnos
DEL II
Region of South Aegean
‚Okužena območja‘
Region of Crete
A. Naslednje regije v Grčiji:
PART II
regija Atika,
“Infected zones”
regija Osrednja Grčija,